Relationship of Hoarding and Depression Symptoms in Older Adults.

Brain Health Registry Late-life depression hoarding disorder major depressive disorder reliable change stability analysis trajectory analysis

Journal

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
ISSN: 1545-7214
Titre abrégé: Am J Geriatr Psychiatry
Pays: England
ID NLM: 9309609

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 10 08 2023
revised: 12 11 2023
accepted: 17 11 2023
pubmed: 14 12 2023
medline: 14 12 2023
entrez: 13 12 2023
Statut: ppublish

Résumé

Hoarding disorder (HD) is a debilitating neuropsychiatric condition that affects 2%-6% of the population and increases in incidence with age. Major depressive disorder (MDD) co-occurs with HD in approximately 50% of cases and leads to increased functional impairment and disability. However, only one study to date has examined the rate and trajectory of hoarding symptoms in older individuals with a lifetime history of MDD, including those with current active depression (late-life depression; LLD). We therefore sought to characterize this potentially distinct phenotype. We determined the incidence of HD in two separate cohorts of participants with LLD (n = 73) or lifetime history of MDD (n = 580) and examined the reliability and stability of hoarding symptoms using the Saving Inventory-Revised (SI-R) and Hoarding Rating Scale-Self Report (HRS), as well as the co-variance of hoarding and depression scores over time. HD was present in 12% to 33% of participants with MDD, with higher rates found in those with active depressive symptoms. Hoarding severity was stable across timepoints in both samples (all correlations >0.75), and fewer than 30% of participants in each sample experienced significant changes in severity between any two timepoints. Change in depression symptoms over time did not co-vary with change in hoarding symptoms. These findings indicate that hoarding is a more common comorbidity in LLD than previously suggested, and should be considered in screening and management of LLD. Future studies should further characterize the interaction of these conditions and their impact on outcomes, particularly functional impairment in this vulnerable population.

Identifiants

pubmed: 38092621
pii: S1064-7481(23)00485-2
doi: 10.1016/j.jagp.2023.11.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-508

Informations de copyright

Copyright © 2023 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Sara Nutley (S)

Department of Psychiatry (SN, BN, CAM), University of Florida College of Medicine, Gainesville, FL; Center for OCD, Anxiety, and Related Disorders (COARD) (SN, BN, CAM), University of Florida, Gainesville, FL; Department of Epidemiology (SN), University of Florida, Gainesville, FL.

Binh K Nguyen (BK)

Department of Psychiatry (SN, BN, CAM), University of Florida College of Medicine, Gainesville, FL; Center for OCD, Anxiety, and Related Disorders (COARD) (SN, BN, CAM), University of Florida, Gainesville, FL.

Robert Scott Mackin (RS)

Department of Psychiatry and Behavioral Sciences (RM, PI, MW, CN, MK, MK-L, RN), University of California, San Francisco, San Francisco, CA; San Francisco Veterans Administration Medical Center (DT, MW, MK, JE), San Francisco, CA.

Philip S Insel (PS)

Department of Psychiatry and Behavioral Sciences (RM, PI, MW, CN, MK, MK-L, RN), University of California, San Francisco, San Francisco, CA.

Duygu Tosun (D)

San Francisco Veterans Administration Medical Center (DT, MW, MK, JE), San Francisco, CA; Department of Radiology (DT, MW, JE, RN), University of California, San Francisco, San Francisco, CA.

Meryl Butters (M)

Department of Psychiatry (MB), University of Pittsburgh School of Medicine, Pittsburgh, PA.

Paul Aisen (P)

University of Southern California (PA, RR), San Diego, CA; Alzheimer's Therapeutic Research Institute (PA, RR), University of Southern California, San Diego, CA.

Rema Raman (R)

University of Southern California (PA, RR), San Diego, CA; Alzheimer's Therapeutic Research Institute (PA, RR), University of Southern California, San Diego, CA.

Andrew J Saykin (AJ)

Indiana Alzheimer's Disease Research Center and Department of Radiology and Imaging Sciences (AS), Indiana University School of Medicine, Indianapolis, IN.

Arthur W Toga (AW)

Laboratory of Neuro Imaging, Stevens Neuroimaging and Informatics Institute, Keck School of Medicine (AT), University of Southern California, Los Angeles, CA.

Clifford Jack (C)

Mayo Clinic (CJ), Rochester, MN.

Michael W Weiner (MW)

Department of Psychiatry and Behavioral Sciences (RM, PI, MW, CN, MK, MK-L, RN), University of California, San Francisco, San Francisco, CA; San Francisco Veterans Administration Medical Center (DT, MW, MK, JE), San Francisco, CA; Department of Radiology (DT, MW, JE, RN), University of California, San Francisco, San Francisco, CA; Department of Neurology (MW), University of California, San Francisco, San Francisco, CA.

Craig Nelson (C)

Department of Psychiatry and Behavioral Sciences (RM, PI, MW, CN, MK, MK-L, RN), University of California, San Francisco, San Francisco, CA.

Michelle Kassel (M)

Department of Psychiatry and Behavioral Sciences (RM, PI, MW, CN, MK, MK-L, RN), University of California, San Francisco, San Francisco, CA; San Francisco Veterans Administration Medical Center (DT, MW, MK, JE), San Francisco, CA.

Maria Kryza-Lacombe (M)

Department of Psychiatry and Behavioral Sciences (RM, PI, MW, CN, MK, MK-L, RN), University of California, San Francisco, San Francisco, CA; Mental Illness Research Education and Clinical Centers (MK-L), Veterans Administration Medical Center, San Francisco, CA.

Joseph Eichenbaum (J)

San Francisco Veterans Administration Medical Center (DT, MW, MK, JE), San Francisco, CA; Department of Radiology (DT, MW, JE, RN), University of California, San Francisco, San Francisco, CA.

Rachel L Nosheny (RL)

Department of Psychiatry and Behavioral Sciences (RM, PI, MW, CN, MK, MK-L, RN), University of California, San Francisco, San Francisco, CA; Department of Radiology (DT, MW, JE, RN), University of California, San Francisco, San Francisco, CA.

Carol A Mathews (CA)

Department of Psychiatry (SN, BN, CAM), University of Florida College of Medicine, Gainesville, FL; Center for OCD, Anxiety, and Related Disorders (COARD) (SN, BN, CAM), University of Florida, Gainesville, FL. Electronic address: carolmathews@ufl.edu.

Classifications MeSH